12,958 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Purchased by Sone Capital Management LLC

Sone Capital Management LLC acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 12,958 shares of the healthcare conglomerate's stock, valued at approximately $6,555,000.

Other hedge funds also recently made changes to their positions in the company. Vident Advisory LLC grew its holdings in shares of UnitedHealth Group by 548.5% in the 4th quarter. Vident Advisory LLC now owns 81,032 shares of the healthcare conglomerate's stock worth $40,992,000 after purchasing an additional 68,536 shares during the last quarter. Vivaldi Capital Management LP grew its holdings in shares of UnitedHealth Group by 1.8% in the 4th quarter. Vivaldi Capital Management LP now owns 2,483 shares of the healthcare conglomerate's stock worth $1,350,000 after purchasing an additional 45 shares during the last quarter. Waters Parkerson & CO. LLC grew its holdings in shares of UnitedHealth Group by 11.5% in the 4th quarter. Waters Parkerson & CO. LLC now owns 1,226 shares of the healthcare conglomerate's stock worth $620,000 after purchasing an additional 126 shares during the last quarter. Westwood Holdings Group Inc. grew its holdings in shares of UnitedHealth Group by 9.6% in the 4th quarter. Westwood Holdings Group Inc. now owns 291,614 shares of the healthcare conglomerate's stock worth $147,516,000 after purchasing an additional 25,637 shares during the last quarter. Finally, Triglav Skladi D.O.O. bought a new stake in shares of UnitedHealth Group in the 4th quarter worth about $23,129,000. Institutional investors and hedge funds own 87.86% of the company's stock.

Analysts Set New Price Targets

UNH has been the topic of a number of research analyst reports. HSBC reissued a "reduce" rating and set a $270.00 price objective (down previously from $490.00) on shares of UnitedHealth Group in a report on Wednesday. TD Securities reissued a "hold" rating and set a $308.00 price objective (down previously from $520.00) on shares of UnitedHealth Group in a report on Monday. Hsbc Global Res lowered shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 22nd. Bank of America lowered shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and decreased their price objective for the stock from $560.00 to $350.00 in a report on Wednesday, May 14th. Finally, Deutsche Bank Aktiengesellschaft decreased their price objective on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a report on Wednesday, May 14th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating, eighteen have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, UnitedHealth Group has a consensus rating of "Moderate Buy" and an average price target of $441.87.

Insider Activity

In other news, Director Timothy Patrick Flynn bought 1,533 shares of the stock in a transaction that occurred on Wednesday, May 14th. The shares were acquired at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the acquisition, the director now owns 6,033 shares in the company, valued at approximately $1,935,386.40. This represents a 34.07% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Stephen J. Hemsley acquired 86,700 shares of the firm's stock in a transaction on Friday, May 16th. The stock was bought at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the acquisition, the chief executive officer now owns 679,493 shares of the company's stock, valued at approximately $196,081,295.01. The trade was a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired 109,408 shares of company stock worth $31,607,768 over the last ninety days. Insiders own 0.33% of the company's stock.

UnitedHealth Group Trading Down 5.8%

UnitedHealth Group stock traded down $18.51 during midday trading on Wednesday, hitting $303.08. 44,719,494 shares of the stock were exchanged, compared to its average volume of 6,430,339. The company has a fifty day simple moving average of $464.33 and a two-hundred day simple moving average of $510.17. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73. The stock has a market capitalization of $274.93 billion, a PE ratio of 19.55, a P/E/G ratio of 1.37 and a beta of 0.56. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the previous year, the firm posted $6.91 EPS. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.77%. UnitedHealth Group's dividend payout ratio (DPR) is presently 35.18%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.